CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 3,750 shares at $4.00 ($15,000)
- 4 Option exercise President and CEO acquired 10,375 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 1,254 shares at $3.78 ($4,740)
- 4 Open-market sale General Counsel sold 899 shares at $3.78 ($3,398)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 100,000 shares at an average $1.85 ($184,613)
- 4 Open-market buy General Counsel bought 5,000 shares at $1.86 ($9,276)
- 4 Open-market buy Director bought 50,000 shares at $1.75 ($87,500)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.79 ($8,950)
- 4 Open-market buy President and CEO bought 20,000 shares at $1.81 ($36,140)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 17 · 329 filings